Publications
283
Citations
5,306
Est. group size
~4
Recurring co-author estimate
Active years
33
Publishing since 1994
Jeffery J. Auletta's research focuses on hematopoietic cell transplantation (HCT) and cellular therapies, particularly in children and adults with blood cancers. His work spans clinical outcomes such as infection risk, immune recovery, and graft-versus-host disease, as well as efforts to identify and reduce disparities in access to transplant and cell therapy care. He also studies vaccine responses, sepsis screening, and workforce diversity within the transplant field.
Publication output has grown substantially over the last decade, rising from around 17-20 papers per year in 2017-2018 to over 40 in 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Antigen-specific T-cell responses to SARS-CoV-2 vaccination after hematopoietic cell transplant or CAR T-cell therapy
Blood Advances · 2026
- Antigen-specific T cell responses to SARS-CoV-2 vaccination after Hematopoietic Cell Transplant or CAR T cell Therapy
UNC Libraries · 2026
- Access Challenges in Allogeneic Hematopoietic Cell Transplant: Identifying At-Risk US States by Exploring Social Vulnerability, Physician Density, and Unmet Need
JCO Oncology Practice · 2026
- A Randomized Clinical Trial Evaluating Lactiplantibacillus Plantarum for the Prevention of GI aGvHD: A Report From the Children’s Oncology Group (ACCL1633)
Transplantation and Cellular Therapy · 2025
- Receiving CAR T-cells gets faster, but not for all in need
Blood Advances · 2025
- Establishment of a machine learning-based prediction framework to assess trade-offs in decisions that affect post-HCT outcomes
Computers in Biology and Medicine · 2025
- Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults
Blood Advances · 2025
- Sepsis Mortality in Hospitalized Children With Cancer Is Associated With Lack of a Screening Tool
Hospital Pediatrics · 2025
- Proceedings From the Second Reimagining Caregiver Workshop: Addressing Caregiver Requirements for Hematopoietic Cell Transplant
Transplantation and Cellular Therapy · 2025
- Proceedings From the Reimagining Caregiver Workshop: Addressing Caregiver Requirements for Hematopoietic Cell Transplant
Transplantation and Cellular Therapy · 2025
- Identifying Disparities in Autologous Hematopoietic Cell Transplantation (autoHCT) Utilization for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in California
Transplantation and Cellular Therapy · 2025
- Perception and Reality of Racial and Ethnic Workforce Diversity in the U.S HCT/CT Workforce: Results from the ASTCT-NMDP Access Initiative Survey
Transplantation and Cellular Therapy · 2025
- Understanding Diversity: An ASTCT-NMDP Access Initiative Survey of the Hematopoietic Cell Transplant and Cellular Therapy Nonphysician Workforce
Transplantation and Cellular Therapy · 2025
- Physician Workforce Diversity in the Hematopoietic Cell Transplant and Cellular Therapy Ecosystem: An ASTCT-NMDP Access Initiative Survey
Transplantation and Cellular Therapy · 2025
- Engaging Stakeholders to Address Allogeneic Hematopoietic Cell Transplant Caregiver Requirement Barriers
Transplantation and Cellular Therapy · 2025
- Transplantation and Cellular Therapy×54
- Blood×39
- Biology of Blood and Marrow Transplantation×35
- Bone Marrow Transplantation×15
- Blood Advances×14
- Rajinder Bajwa
Medicine · The Ohio State University
- Neha Rastogi
Medicine · The Ohio State University
- April Rahrig
Medicine · Indiana University
- Hannah Choe
Medicine · The Ohio State University
- Ayman Saad
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile